Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OCUL Ocular Therapeutix

盘后交易 11-10 16:19:18 EST

6.61

-0.24

-3.50%

盘后6.61

+0.000.00%

16:15 EST

最高6.87	最低6.60	成交量243.65万
今开6.86	昨收6.85	日振幅3.94%
总市值14.47亿	流通市值12.23亿	总股本2.19亿
成交额1,624万	换手率1.32%	流通股本1.85亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"OCUL","market":"US","secType":"STK","nameCN":"Ocular Therapeutix","latestPrice":6.61,"timestamp":1794344400000,"preClose":6.85,"halted":0,"volume":2436506,"hourTrading":{"tag":"盘后","latestPrice":6.61,"preClose":6.61,"latestTime":"16:15 EST","volume":61581,"amount":407050.41000000003,"timestamp":1794345300264,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03503649635036487,"floatShares":185000000,"shares":218906099,"eps":-1.414022,"marketStatus":"盘后交易","change":-0.24,"latestTime":"11-10 16:19:18 EST","open":6.86,"high":6.87,"low":6.6,"amount":16240917,"amplitude":0.039416,"askPrice":6.95,"askSize":410,"bidPrice":6.51,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-1.414022,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1794358800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1406260800000,"exchange":"NASDAQ","adjPreClose":6.85,"preHourTrading":{"tag":"盘前","latestPrice":6.83,"preClose":6.85,"latestTime":"09:29 EST","volume":13056,"amount":89389.18348800001,"timestamp":1794320999999,"change":-0.02,"changeRate":-0.00292,"amplitude":0.189781},"postHourTrading":{"tag":"盘后","latestPrice":6.61,"preClose":6.61,"latestTime":"16:15 EST","volume":61581,"amount":407050.41000000003,"timestamp":1794345300264,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.869841,"impliedVol":0.287,"impliedVolPercentile":0.0359},"requestUrl":"/m/hq/s/OCUL","defaultTab":"news","newsList":[{"id":"1169809621","title":"财报前瞻 | Ocular Therapeutix本季度营收预计小幅下滑，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1169809621","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169809621?lang=zh_cn&edition=full","pubTime":"2026-11-03 00:06","pubTimestamp":1793635589,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix将于2026年11月09日美股盘前发布最新季度财报，市场聚焦收入变化与亏损收窄节奏及关键管线推进进展。当前一致预期显示，本季度公司营收预计为美元1,422.42万，同比下降2.75%；调整后每股收益预计为-0.36美元，同比改善1.26%；息税前利润预计为亏损美元8,613.64万，同比扩大28.58%。近期机构观点以看多为主。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | Ocular Therapeutix本季度营收预计小幅下滑，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123000074","title":"竞争对手EyePoint眼科药物晚期试验未达主要终点，Ocular Therapeutix盘前股价飙升12.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123000074","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123000074?lang=zh_cn&edition=full","pubTime":"2026-08-17 20:53","pubTimestamp":1786971190,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix的股价在盘前交易中大涨12.7%，此前其竞争对手EyePoint Pharmaceuticals所研发的眼科药物，在一项晚期临床试验中未能达成主要疗效目标。这一消息犹如一剂强心针，瞬间点燃了投资者对Ocular Therapeutix的热情。盘前交易时段，该公司股价迅速攀升，涨幅高达12.7%。这一失利，对于EyePoint而言，无疑是一次沉重的打击。而对于Ocular Therapeutix而言，对手的挫折反倒成了自己的利好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117854803","title":"Ocular Therapeutix计划通过505(B)(2)途径提交新药申请，有望加速审评流程长达60天","url":"https://stock-news.laohu8.com/highlight/detail?id=1117854803","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117854803?lang=zh_cn&edition=full","pubTime":"2026-06-17 20:48","pubTimestamp":1781700512,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix公司宣布，计划依据505监管途径提交其新药申请。这一策略选择有望将审评时间线最多缩短60天，从而可能加快其候选产品进入市场的步伐。505途径允许申办方部分依赖美国食品药品监督管理局对已获批药品的安全性及有效性数据，同时提交自身的新临床数据。相较于传统的505新药申请，该路径通常能提供更高效、资源需求更少的审评流程。对于Ocular Therapeutix而言，采用此途径标志着其产品开发策略的关键一步，旨在优化监管时间表并提升效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157065067","title":"Ocular Therapeutix投资者日将重点展示与FDA就Axpaxli™新药申请达成一致，计划于2026年第四季度提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1157065067","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157065067?lang=zh_cn&edition=full","pubTime":"2026-06-17 20:45","pubTimestamp":1781700330,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix宣布，即将举行的投资者日活动将重点展示其与**美国食品药品监督管理局**就**Axpaxli™**新药申请所达成的共识。公司计划于**2026年第四季度**正式提交该申请。这一进展标志着该候选药物在监管路径上迈出了关键一步，备受投资者关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518440695","title":"Ocular Therapeutix, Inc.2024财年实现净利润-1.94亿美元，同比减少140.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518440695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518440695?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449669,"startTime":"0","endTime":"0","summary":"3月9日，Ocular Therapeutix, Inc.公布财报，公告显示公司2024财年净利润为-1.94亿美元，同比减少140.28%；其中营业收入为63.72百万美元，同比增加9.03%，每股基本收益为-1.22美元。从资产负债表来看，Ocular Therapeutix, Inc.总负债1.43亿美元，其中短期债务1.93百万美元，资产负债比为3.21，流动比率为0.11。机构评级：截至2025年3月9日，当前有10家机构对Ocular Therapeutix, Inc.目标价做出预测，其中目标均价为17.90美元，其中最低目标价为14.00美元，最高目标价为22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000230abef9832&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000230abef9832&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517543948","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517543948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517543948?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:43","pubTimestamp":1741185809,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时43分，Ocular Therapeutix, Inc.股票出现波动，股价大幅上涨5.23%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为447.21%、265.62%、205.52%，振幅较大的相关个股有Silexion Therapeutics Corp、Aditxt, Inc.、Radiopharm Theranostics Limited，振幅分别为25.23%、23.90%、23.49%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224329abe9b4a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224329abe9b4a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517606781","title":"Ocular Therapeutix, Inc.盘中异动 早盘快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517606781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517606781?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:28","pubTimestamp":1741102080,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时28分，Ocular Therapeutix, Inc.股票出现异动，股价急速拉升5.15%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1175.00%、1136.55%、697.38%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 ，振幅分别为100.00%、70.63%、66.67%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232800abe80038&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232800abe80038&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516321672","title":"Citizens Capital Markets：维持Ocular Therapeutix(OCUL.US)评级，由优于大市调整至优于大市评级, 目标价由22.00美元调整至19.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516321672","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516321672?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:22","pubTimestamp":1741098129,"startTime":"0","endTime":"0","summary":"Citizens Capital Markets：维持Ocular Therapeutix(OCUL.US)评级，由优于大市调整至优于大市评级, 目标价由22.00美元调整至19.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04222248521892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516796634","title":"Ocular Therapeutix, Inc.盘中异动 早盘大幅下跌5.74%报6.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516796634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516796634?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:44","pubTimestamp":1741013071,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时44分，Ocular Therapeutix, Inc.股票出现异动，股价大幅跳水5.74%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Aldeyra Therapeutics, Inc.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Entero Therapeutics Inc.、Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为99.66%、52.66%、43.38%，振幅较大的相关个股有Entero Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为55.45%、24.83%、22.27%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224431abe6377b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224431abe6377b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516268034","title":"Ocular Therapeutix(OCUL.US)：2024年Q4财报实现营收1708.3万美元，前值为1480.2万美元，预期值为1689万美元；每股收益为-0.29美元，前值为-0.35美元，预期值为-0.22美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516268034","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516268034?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:13","pubTimestamp":1741003981,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix(OCUL.US)：2024年Q4财报实现营收1708.3万美元，前值为1480.2万美元，预期值为1689万美元；每股收益为-0.29美元，前值为-0.35美元，预期值为-0.22美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03201348492142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133495113","title":"Ocular Therapeutix公司2024年第四季度GAAP每股收益$(0.29) 不及预期$(0.24), 销售额$1708万 不及预期$1720万","url":"https://stock-news.laohu8.com/highlight/detail?id=1133495113","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133495113?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:10","pubTimestamp":1741003823,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix报告其季度每股亏损为$，低于分析师普遍预期的$，差异为20.83%。与去年同期每股亏损$相比，这一数字增加了17.14%。该公司报告季度销售额为1708万美元，低于分析师普遍预期的1720万美元，差异为0.71%。以上内容来自Benzinga Earnings专栏，原文如下：$Ocular Therapeutix$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 20.83 percent. This is a 17.14 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $17.08 million which missed the analyst consensus estimate of $17.20 million by 0","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Ocular Therapeutix公司2024年第四季度GAAP每股收益$(0.29) 不及预期$(0.24), 销售额$1708万 不及预期$1720万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509785598","title":"Ocular Therapeutix, Inc.盘中异动 股价大跌5.04%报7.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509785598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509785598?lang=zh_cn&edition=full","pubTime":"2025-02-07 03:37","pubTimestamp":1738870629,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日03时37分，Ocular Therapeutix, Inc.股票出现波动，股价急速下跌5.04%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Lipella Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025、Transcode Therapeutics, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为6930.13%、1744.72%、179.03%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为125.58%、69.09%、64.30%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207033710987cb9d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207033710987cb9d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509235336","title":"Ocular Therapeutix, Inc.盘中异动 大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509235336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509235336?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:50","pubTimestamp":1738770656,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时50分，Ocular Therapeutix, Inc.股票出现异动，股价急速拉升5.00%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。其相关个股中，Oragenics Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4112.35%、1233.08%、1082.07%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为86.20%、59.80%、54.05%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502052350569619176f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502052350569619176f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503640182","title":"Ocular Therapeutix, Inc.盘中异动 急速拉升5.09%报8.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503640182?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951541,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Ocular Therapeutix, Inc.股票出现波动，股价大幅上涨5.09%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.07%、53.26%、35.43%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Eterna Therapeutics Inc.，振幅分别为14.29%、12.00%、11.55%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223222a222fe17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223222a222fe17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503865686","title":"Ocular Therapeutix, Inc.盘中异动 快速下挫5.05%报7.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503865686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503865686?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:10","pubTimestamp":1736885433,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时10分，Ocular Therapeutix, Inc.股票出现异动，股价快速跳水5.05%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为1.23%。其相关个股中，Eterna Therapeutics Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃，换手率分别为1084.20%、603.99%、421.77%，振幅较大的相关个股有Eterna Therapeutics Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Matinas Biopharma Holdings, Inc.，振幅分别为170.74%、146.24%、69.81%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115041033a221ff6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115041033a221ff6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503826815","title":"Ocular Therapeutix, Inc.盘中异动 急速跳水5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503826815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503826815?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:00","pubTimestamp":1736784018,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时00分，Ocular Therapeutix, Inc.股票出现异动，股价大幅下跌5.12%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为0.89%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为10786.38%、5856.41%、421.82%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、216.61%、124.54%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140000189602632a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140000189602632a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502892469","title":"Ocular Therapeutix, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502892469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502892469?lang=zh_cn&edition=full","pubTime":"2025-01-11 00:58","pubTimestamp":1736528337,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日00时58分，Ocular Therapeutix, Inc.股票出现波动，股价急速跳水5.07%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为1.78%。其相关个股中，Conduit Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Omniab Inc C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1214.48%、806.15%、227.33%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为108.20%、100.85%、64.55%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111005858a21d301c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111005858a21d301c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492553711","title":"Ocular Therapeutix, Inc.盘中异动 股价大跌5.10%报8.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492553711","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492553711?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:00","pubTimestamp":1734552020,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时00分，Ocular Therapeutix, Inc.股票出现波动，股价急速下挫5.10%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为1.89%。其相关个股中，Polyrizon Ltd.、Tc Biopharm  Plc C/Wts 10/02/2028 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3176.65%、663.05%、346.50%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、138.10%、105.17%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040020984cb7a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040020984cb7a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491306643","title":"Ocular Therapeutix, Inc.盘中异动 下午盘快速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491306643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491306643?lang=zh_cn&edition=full","pubTime":"2024-12-13 02:02","pubTimestamp":1734026569,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日02时02分，Ocular Therapeutix, Inc.股票出现异动，股价快速下跌5.13%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为1.04%。其相关个股中，Trevi Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为3876.16%、88.43%、79.88%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Palisade Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为129.16%、99.29%、86.92%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213020249ab730820&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213020249ab730820&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2490743887","title":"Ocular Therapeutix, Inc.盘中异动 早盘急速下跌5.20%报9.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490743887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490743887?lang=zh_cn&edition=full","pubTime":"2024-12-09 23:49","pubTimestamp":1733759383,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日23时49分，Ocular Therapeutix, Inc.股票出现异动，股价急速下跌5.20%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Reviva Pharmaceuticals Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Dermata Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为5050.40%、41.73%、31.69%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Reviva Pharmaceuticals Holdings, Inc.、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为224.91%、154.55%、91.43%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209234943a1e0d1f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209234943a1e0d1f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocutx.com","stockEarnings":[{"period":"1week","weight":0.0178},{"period":"1month","weight":-0.0915},{"period":"3month","weight":-0.2982},{"period":"6month","weight":-0.2587},{"period":"1year","weight":-0.3687},{"period":"ytd","weight":-0.4357}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0332},{"period":"3month","weight":-0.0232},{"period":"6month","weight":0.014},{"period":"1year","weight":0.1218},{"period":"ytd","weight":0.1038}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ocular Therapeutix, Inc.于2006年9月12号在特拉华州成立。该公司是一家综合生物制药公司，专注于开发视网膜疾病和其他眼部疾病的治疗方法。其主要候选药物AXPAXLI（OTX-TKI）是一种用于湿性年龄相关性黄斑变性和糖尿病视网膜疾病的研究性阿昔替尼玻璃体腔内水凝胶，目前处于3期注册试验阶段。该公司还将DEXTENZA商业化，这是一种FDA批准的用于术后炎症和眼痒的皮质类固醇插入物，并基于其专有的ELUTYX生物可吸收水凝胶技术推进其他候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":-0.013324},{"month":2,"riseRate":0.666667,"avgChangeRate":0.204982},{"month":3,"riseRate":0.5,"avgChangeRate":0.019654},{"month":4,"riseRate":0.583333,"avgChangeRate":-0.023422},{"month":5,"riseRate":0.5,"avgChangeRate":0.000387},{"month":6,"riseRate":0.5,"avgChangeRate":0.03349},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.035731},{"month":8,"riseRate":0.615385,"avgChangeRate":0.080775},{"month":9,"riseRate":0.153846,"avgChangeRate":-0.104509},{"month":10,"riseRate":0.307692,"avgChangeRate":-0.078241},{"month":11,"riseRate":0.615385,"avgChangeRate":0.128195},{"month":12,"riseRate":0.416667,"avgChangeRate":0.063013}],"exchange":"NASDAQ","name":"Ocular Therapeutix","nameEN":"Ocular Therapeutix"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ocular Therapeutix(OCUL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ocular Therapeutix,OCUL,Ocular Therapeutix股票,Ocular Therapeutix股票老虎,Ocular Therapeutix股票老虎国际,Ocular Therapeutix行情,Ocular Therapeutix股票行情,Ocular Therapeutix股价,Ocular Therapeutix股市,Ocular Therapeutix股票价格,Ocular Therapeutix股票交易,Ocular Therapeutix股票购买,Ocular Therapeutix股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ocular Therapeutix(OCUL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}